TY - JOUR
T1 - Lymph node metastasis in T4 maxillary sinus squamous cell carcinoma
T2 - Incidence and treatment outcome
AU - Homma, Akihiro
AU - Hayashi, Ryuichi
AU - Matsuura, Kazuto
AU - Kato, Kengo
AU - Kawabata, Kazuyoshi
AU - Monden, Nobuya
AU - Hasegawa, Yasuhisa
AU - Onitsuka, Tetsuro
AU - Fujimoto, Yasushi
AU - Iwae, Shigemichi
AU - Okami, Kenji
AU - Matsuzuka, Takashi
AU - Yoshino, Kunitoshi
AU - Nibu, Ken Ichi
AU - Kato, Takakuni
AU - Nishino, Hiroshi
AU - Asakage, Takahiro
AU - Ota, Ichiro
AU - Kitamura, Morimasa
AU - Kubota, Akira
AU - Ueda, Tsutomu
AU - Ikebuchi, Kaichiro
AU - Watanabe, Akihito
AU - Fujii, Masato
N1 - Funding Information:
ACKNOWLEDGMENT This study was supported in part by a Health and Labour Sciences Research Grant for Clinical Cancer Research (H22-Gannrinshou-Ippan-017) from the Ministry of Health, Labour and Welfare of Japan, the National Cancer Center Research and Development Fund (23-A-21) of Japan, and a grant-in-aid for Scientific Research (C) (KAKENHI 24592587) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. In addition to the authors, the following investigators participated in this study: National Cancer Center Hospital East, Kashiwa—T. Shino-hara; Miyagi Cancer Center, Sendai—Y. Asada; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo—T. Sa-saki; Aichi Cancer Center, Nagoya—H. Hirakawa; Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka—T. Fujii; Kobe University Graduate School of Medicine—N. Otsuki; Tokyo University—Y. Saito; Aichi Medical University, Nagakute—A. Ike-da; Iwate Prefectural Central Hospital, Morioka—S. Kato; Kochi Health Sciences Center, Kochi—K. Kozakura; Japanese Red Cross Nagoya Daiichi Hospital, Nagoya—K. Kawata and A. Terada.
PY - 2014/5/1
Y1 - 2014/5/1
N2 - Background: The purpose of this study was to evaluate the incidence of lymph node metastasis among patients with T4 maxillary sinus squamous cell carcinoma (MS-SCC) as well as the delayed metastasis rate and the treatment outcome for untreated N0 neck in patients with T4 MS-SCC. Methods: Consecutive series of all patients (n = 128) with previously untreated T4 maxillary sinus SCC between 2006 and 2007 were obtained from 28 institutions belonging to or cooperating in the Head and Neck Cancer Study Group of the Japan Clinical Oncology Group. Results: Of the 128 patients, 28 (21.9 %) had lymph node metastasis, and six patients (4.7 %) had distant metastasis at diagnosis. Among the 111 patients who were treated with curative intent, 98 had clinically N0 neck disease and did not receive prophylactic neck irradiation. A total of 11 patients (11.2 %) subsequently developed evidence of lymph node metastasis, of whom eight were among the 83 patients with an N0 neck and had not received elective neck treatment. There were 15 patients who received an elective neck dissection as part of the initial treatment, of whom three had pathologically positive for lymph node metastases. Of 11 patients, six patients with nonlateral retropharyngeal lymph node metastasis without primary or distant disease were successfully salvaged. Conclusions: This study identified the incidence of lymph node metastasis among patients with T4 MS-SCC as well as the delayed metastasis rate and the treatment outcome for untreated N0 neck in patients with T4 MS-SCC. These results will be of assistance in selecting treatment strategy for T4 MS-SCC in the future.
AB - Background: The purpose of this study was to evaluate the incidence of lymph node metastasis among patients with T4 maxillary sinus squamous cell carcinoma (MS-SCC) as well as the delayed metastasis rate and the treatment outcome for untreated N0 neck in patients with T4 MS-SCC. Methods: Consecutive series of all patients (n = 128) with previously untreated T4 maxillary sinus SCC between 2006 and 2007 were obtained from 28 institutions belonging to or cooperating in the Head and Neck Cancer Study Group of the Japan Clinical Oncology Group. Results: Of the 128 patients, 28 (21.9 %) had lymph node metastasis, and six patients (4.7 %) had distant metastasis at diagnosis. Among the 111 patients who were treated with curative intent, 98 had clinically N0 neck disease and did not receive prophylactic neck irradiation. A total of 11 patients (11.2 %) subsequently developed evidence of lymph node metastasis, of whom eight were among the 83 patients with an N0 neck and had not received elective neck treatment. There were 15 patients who received an elective neck dissection as part of the initial treatment, of whom three had pathologically positive for lymph node metastases. Of 11 patients, six patients with nonlateral retropharyngeal lymph node metastasis without primary or distant disease were successfully salvaged. Conclusions: This study identified the incidence of lymph node metastasis among patients with T4 MS-SCC as well as the delayed metastasis rate and the treatment outcome for untreated N0 neck in patients with T4 MS-SCC. These results will be of assistance in selecting treatment strategy for T4 MS-SCC in the future.
UR - http://www.scopus.com/inward/record.url?scp=84898845467&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84898845467&partnerID=8YFLogxK
U2 - 10.1245/s10434-014-3544-6
DO - 10.1245/s10434-014-3544-6
M3 - Article
C2 - 24554063
AN - SCOPUS:84898845467
VL - 21
SP - 1706
EP - 1710
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
SN - 1068-9265
IS - 5
ER -
